Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-29

Clinical Trial Update: Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of fish oil (omega-3 fatty acids) on arterial health was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil (omega-3 fatty acids) (omega-3 fatty acids)

Snippet

Sponsor: Denver Health and Hospital Authority | Conditions: Metabolic Diseases, Endocrine System Diseases | Phase 3 | Status: TERMINATED | Results posted: 2014-09-29